Where does Sharon Stevenson work?

Sharon Stevenson is Co-Founder, Managing Director, Venture Partner at Okapi Venture Capital and Board director at BioTrace Medical and Board director at Obalon Therapeutics, Inc. and Board director at Focal Therapeutics.

What check size does Sharon Stevenson write?

Sharon Stevenson typically writes checks of $750K – $3M.

What boards does Sharon Stevenson sit on?

Sharon Stevenson holds tracked board seats at BioTrace Medical, Focal Therapeutics.

What companies has Sharon Stevenson invested in?

Investments tracked here include Helixis, PathCentral, BioTrace Medical, BioTrace Medical, Focal Therapeutics, Orthalign, Welltok, WiserCare.

Where did Sharon Stevenson go to school?

Sharon Stevenson studied at UCLA Extension (Certificate, Patient Advocacy); University of California, Davis (PhD, Comparative Pathology); The Ohio State University (DVM Summa cum Laude, MS Pathology).

Does Sharon Stevenson lead rounds?

Yes — Sharon Stevenson has led 2 tracked investments.

Sharon Stevenson

Investor

Co-Founder, Managing Director, Venture Partner at Okapi Venture Capital · Board director at BioTrace Medical · Board director at Obalon Therapeutics, Inc. · Board director at Focal Therapeutics

Laguna Beach, California, United States

Writes $750K – $3M checks · typically $500K

Find your path to Sharon

100 people in our graph share verified history with Sharon — schools, employers, funds. One of them is your warm intro.

Brian HalakunlockedSharon: together at Domain Associates (2001–2003)

×3Sharon: together at Domain Associates

×2Sharon: together at Okapi Venture Capital

Sharon: together at UCLA Extension

About

Co-founder of Okapi in 2005, Sharon leads the firm's life science investments and previously was a principal at Domain Associates and an executive at SkinMedica and Volcano Therapeutics. She holds DVM, PhD, and MBA degrees and was formerly a tenured professor at Case Western Reserve.

Contact· self-published, not guessed

s•••@okapivc.comreveal

Invests in

AI & Machine LearningConsumerEnterprise SoftwareFuture of WorkSaaS

Board director at BioTrace Medical

Intro paths

→

In turn, Sharon can intro founders to BioTrace Medical's investors below.

BioTrace Medical's investors · 2

Emergent Medical Partners, LLPSan Jose Okapi Venture CapitalNewport Beach · $750K – $3M checks · since 2021

Board director at Obalon Therapeutics, Inc.

Intro paths

→

In turn, Sharon can intro founders to Obalon Therapeutics, Inc.'s investors below.

Obalon Therapeutics, Inc.'s investors · 1

Okapi Venture CapitalNewport Beach · $750K – $3M checks · since 2018

Board director at Focal Therapeutics

Intro paths

→

In turn, Sharon can intro founders to Focal Therapeutics's investors below.

Focal Therapeutics's investors · 2

Emergent Medical Partners, LLPSan Jose Okapi Venture CapitalNewport Beach · $750K – $3M checks · since 2016

Experience

UCLA Law Master of Legal StudiesGraduate Studentcurrent2026 — presentUCLA
Okapi Venture CapitalCo-founder and Managing Directorcurrent2005 — presentLaguna Beach, CA
CaringInfo.org a Program of the Alliance for Care at HomeProgram Manager2020 — 2025
Bellwether Care, Inc.Founder and President2016 — 2025Laguna Beach, CA
SkinMedicaSenior VP, Technology2003 — 2004
Domain AssociatesPrincipal2000 — 2003
NeoCyte Joint VentureExecutive Director1997 — 2000
CWRU Department of OrthopaedicsAssociate Professor1985 — 1997

Skills & more

Pharmaceutical Industry1Strategy8Venture Capital20Start-ups20Corporate Development8Medical Devices3Lifesciences5Venture Financing5Healthcare4Biotechnology3FDAEntrepreneurship15

+8 more

CommercializationInvestmentsAngel InvestingDue DiligenceMergers & AcquisitionsTechnology TransferExecutive ManagementLife Sciences

From Sharon's professional profile.

Deals · 2

BioTrace MedicalBoard seat

via Okapi Venture Capital · filed Mar 2021 · $16.3M raise

Focal TherapeuticsBoard seat

via Okapi Venture Capital · filed Jan 2017 · $48.9K raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Led

HelixisPathCentral

Investor

Orthalign Welltok WiserCare

Sources: curated public sources · SEC Form D filings.

Colleagues at Okapi Venture Capital

B. Marc Averitt

General Partner at Okapi Venture Capital

Jeff Bocan

Managing Director at Okapi Venture Capital

John Walker

General Partner at Okapi Venture Capital

Marc Averitt

Co-Founder, Managing Director at Okapi Venture Capital

Frequently asked questions

Who is Sharon Stevenson?: Co-founder of Okapi in 2005, Sharon leads the firm's life science investments and previously was a principal at Domain Associates and an executive at SkinMedica and Volcano Therapeutics. She holds DVM, PhD, and MBA degrees and was formerly a tenured professor at Case Western Reserve.
Where does Sharon Stevenson work?: Sharon Stevenson is Co-Founder, Managing Director, Venture Partner at Okapi Venture Capital and Board director at BioTrace Medical and Board director at Obalon Therapeutics, Inc. and Board director at Focal Therapeutics.
What does Sharon Stevenson invest in?: Sharon Stevenson invests in AI & Machine Learning, Consumer, Enterprise Software, Future of Work, SaaS.
What check size does Sharon Stevenson write?: Sharon Stevenson typically writes checks of $750K – $3M.
What boards does Sharon Stevenson sit on?: Sharon Stevenson holds tracked board seats at BioTrace Medical, Focal Therapeutics.
What companies has Sharon Stevenson invested in?: Investments tracked here include Helixis, PathCentral, BioTrace Medical, BioTrace Medical, Focal Therapeutics, Orthalign, Welltok, WiserCare.
Where did Sharon Stevenson go to school?: Sharon Stevenson studied at UCLA Extension (Certificate, Patient Advocacy); University of California, Davis (PhD, Comparative Pathology); The Ohio State University (DVM Summa cum Laude, MS Pathology).
Does Sharon Stevenson lead rounds?: Yes — Sharon Stevenson has led 2 tracked investments.

Same school

Also attended UCLA Extension28

Nikolai RiiberInvestor at Investinor Victoria SamlandController at Declaration Partners Amarit CharoenphanInvestor at NZVC Jessica VargasExecutive Assistant at Griffin Gaming Partners Guilherme HadlichPartner at Cubit Capital Nick SeraydarianManaging Director at SG Credit Partners

+ 22 more

Also attended University of California, Davis342

Charles CallSLP & Venture Partner at Cottonwood Technology Fund David PhuController at Felicis Ventures Teresa ChanChief Financial Officer at Felicis Ventures Bryan EglanDirector of Business Development at Menlo Ventures DennisDirector of Trading at Pantera Capital Scott MaxwellInvestor at OpenView Venture Partners

+ 336 more

Also attended UCLA Anderson School of Management419

David Clark GuillermoInvestments at Impact America Fund Dana MoralyPartner; Chief Financial & Administrative Officer at March Capital Partners Jed LeidheiserPartner at March Capital Partners Shahin FarshchiPartner at Lux Capital Monica PlazaOperating Partner at CapitalG Jennifer SavagePartner at Illuminate Ventures

+ 413 more

Also attended University of California, Los Angeles - School of Law55

Az VirjiGeneral Counsel at Marlin Equity Partners Jason DorenGeneral Counsel at ARCH Venture Partners Matthew StepkaManaging Partner at Machina Ventures Dana PollickGeneral Counsel at K5 Global Mai AlashgarChief Legal Officer at SVC Zach Bratun-GlennonGeneral Partner at Gradient Ventures

+ 49 more

Shared employers

Also worked at SkinMedica2

Diane GoostreeFounder at Alastin Skincare Mary FisherExecutive Officer, Director at Colorescience

Also worked at Domain Associates8

Eric HeilManaging Partner at Medical Excellence Capital Kim KamdarManaging Partner at Medical Excellence Capital Brian HalakManaging Partner at Medical Excellence Capital Nicole VitulloInvestor at Arboretum Ventures Nimesh ShahManaging Director at K2 HealthVentures Dennis PodlesakVenture Partner at Domain Associates

+ 2 more